Background {#Sec1}
==========

Lung--protective ventilation strategies are increasingly used in surgical patients \[[@CR1], [@CR2]\]. Typical lung--protective strategies include the use of a low tidal volume (V~T~) and a low plateau pressure (Pplat), with moderate positive end--expiratory pressure (PEEP) and use of recruitment manoeuvres (RM) if needed \[[@CR1], [@CR2]\]. Among these settings, a low V~T~ seems to have the most protective effects compared with moderate or high PEEP \[[@CR3], [@CR4]\].

However, lung--protective ventilation is rarely used in brain injured patients, in whom median V~T~ is generally 9 ml/kg of predicted body weight (PBW) \[[@CR5]\]. The role of intraoperative ventilator settings and their potential impacts on the development of postoperative complications (PPCs) has been scarcely evaluated in neurological patients \[[@CR6]\]. Typically, patients with neurosurgical pathologies have been excluded from most trials on protective intraoperative ventilation. This may be because lung--protective strategies could have detrimental effects on cerebrovascular physiology, and thus might be potentially contraindicated in acute neurosurgical patients \[[@CR7]\]. Moreover, just few and inconclusive data exist regarding the ventilator settings applied in patients undergoing spinal surgery and the incidence of PPCs in this population \[[@CR8], [@CR9]\].

We therefore conducted a post-hoc analysis of the 'Local ASsessment ofVEntilatory management during General Anaesthesia for Surgery--study' (LAS VEGAS), a conveniently sized international observational study in the operating rooms of patients receiving mechanical ventilation \[[@CR10]\]. We focused on neurosurgical patients, including patients undergoing brain or spine surgery. The aims of this analysis were to assess which ventilator strategies were used in neurosurgical patients during general anaesthesia, and to assess the incidence of PPCs and risk factors (including type of surgery, ventilator settings, risk for PPCs) associated with the development of PPCs. The main hypothesis tested was that neurosurgical patients are ventilated with high tidal volume and low positive end expiratory pressure, and that intraoperative ventilator settings can have an effect on PPCs development.

Methods {#Sec2}
=======

LAS VEGAS study {#Sec3}
---------------

This article is reported as per Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines ([www.strobe-statemenent.org](http://www.strobe-statemenent.org)) (Electronic supplementary material ESM Table [S1](#MOESM1){ref-type="media"}).

LAS VEGAS \[[@CR8]\] was an international multicentre observational prospective study (registered at www. clinicaltrials.gov (study identifier NCT01601223)), endorsed and supported by the European Society of Anaesthesiology and the Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands. Details about the LAS VEGAS study collaborators, participating centres and hospital characteristics of participating centres are reported in ESM Tables [S2](#MOESM1){ref-type="media"}a, b and [S3](#MOESM1){ref-type="media"}.

All adult patients requiring invasive ventilation for surgical procedures in a time window of 7 days were included. Exclusion criteria were: age under 18 years, obstetric procedures, recent ventilation before surgery (\< 28 days), surgical procedures not performed in the operating room, and interventions requiring cardiopulmonary bypass.

For this study, we restricted the analysis to patients receiving intraoperative ventilation for neurosurgical procedures (brain or spine surgery) (ESM Flow Chart).

Data collection {#Sec4}
---------------

After inclusion, the following data were collected: patients' baseline and demographic characteristics; the assess respiratory risk in surgical patients in Catalonia (ARISCAT) score \[[@CR11]\]; American Society of Anaesthesiologists (ASA) scale; details on the surgical procedure including intraoperative hourly vital parameters and ventilation data (mode of ventilation, fraction of inspired oxygen (FiO~2~), V~T~, PEEP, peak pressure (Ppeak), respiratory rate (RR)), end-tidal CO~2~ (ETCO~2~), oxygen saturation (SpO~2~), number and type of recruitment manoeuvres, and intraoperative complications.

Recruitment manoeuvres were defined as 'rescue' when the recruitment manoeuvre was not part of the planned ventilation strategy and defined as 'planned' if it was part of routine ventilation practice (ESM Table [S4](#MOESM1){ref-type="media"}). Mechanical power (MP) was calculated according to the following formula \[[@CR12]\]: 0.098 x V~T~ x RR x \[Ppeak x (Pplat - PEEP)/2\]. Hourly data were collected starting at the induction of anaesthesia (T1/40) and then hourly until the end of anaesthesia, up to the 7th hour of surgery (T1/47).

Endpoints {#Sec5}
---------

The primary endpoint was to describe the current practice and ventilator strategies in patients undergoing neurosurgical interventions, in particular ventilator mode, V~T~, PEEP, driving pressure, Ppeak and Pplat and RR, as well as mechanical power.

The secondary outcome was to assess the prevalence of PPCs and the association with preoperative and intraoperative variables including mechanical ventilator settings, type of surgery, ARISCAT score. Detailed definitions of the composites of PPCs and severe PPCs are provided in ESM Table [S5](#MOESM1){ref-type="media"}. Intraoperative complications included desaturation, rescue recruitment manoeuvres, need for airway pressure reduction, expiratory flow limitation, hypotension and use of vasoactive drugs, onset of a new cardiac arrhythmia (ESM Table [S6](#MOESM1){ref-type="media"}). The occurrence of each type of PPC was monitored until hospital discharge, but maximum up to postoperative day 5.

Other secondary endpoints included the occurrence of severe PPCs, intraoperative complications, in-hospital mortality and length of hospital stay.

### Statistical analysis {#Sec6}

Patients were stratified into groups based on type of surgery (brain and spine), the occurrence of PPCs and risk for PPC according to ARISCAT (low risk \[ARISCAT \< 26\] vs. moderate-to-high risk \[ARISCAT ≥26\]. Continuous variables are expressed as mean ± standard deviation (SD) or median (interquartile range \[IQR\]) per variable distribution. Discrete variables are presented as percentages. Baseline characteristics among type of neurosurgery were compared by either t-test, Wilcoxon rank-sum test, or chi-squared tests, as appropriate. The effect of type of neurosurgery on the incidence (per 10 P-days) of in-hospital PPC, severe PPC, and discharged alive was evaluated using log-rank test (stratified by centre); differences in survival probabilities and hospital discharge were depicted with an outcome-specific Kaplan-Meier plot.

A multivariable regression model was built, with PPC as dependent variables. Because this outcome is binary (0/1), a logistic regression analysis was applied. Candidate covariates were chosen based on previous medical knowledge, independent of their *p*-value. From this preliminary selection, those variables with *P* \< 0.20 in the univariate analysis were preferentially chosen for the stepwise procedure. Then, a reduced and parsimonious model was derived using backward stepwise selection. During this selection process, the linearity assumption for continuous variables was tested and transformed, if appropriate, with fractional polynomials (14). In all regression models, the Huber/White/sandwich estimator of variance correction was applied to account for any clustering effect due to centre sampling.

We set a two-sided *p* value of \< 0.05 as the threshold for statistical significance. Stata 15.1 (Stata Statistical Software, release 15 \[2017\] (Stata Corp LP, College Station, TX, USA), and R (Version 3.5.3; R Foundation for Statistical Computing, Vienna, Austria) were used.

Results {#Sec7}
=======

A total of 784 patients were included in the analysis. Of these, 408 (52%) underwent spine surgery and 376(48%) brain surgery. The characteristics of the patients according to subgroups are described in Table [1](#Tab1){ref-type="table"}. Patients with moderate-to-high risk for PPCs- compared to those at low risk were older, with a higher incidence of co-morbidities (in particular chronic kidney failure), worse ASA physical status, and worse pre-hospital functional status and preoperative conditions (as for laboratory tests and vital signs) (Table [1](#Tab1){ref-type="table"}). Patients who developed PPCs were older, with more frequent co-morbidities (in particular respiratory and cardiological), worse ASA and preoperative functional status (Table [1](#Tab1){ref-type="table"}). Table 1Pre-Operative Characteristics of the Patients According to SubgroupsAll PatientsBrainSpine***p*** valueAll patientsPPCNo PPC***p*** valueAll patientsARISCAT \< 26ARISCAT ≥ 26***p*** value***n (%)***784 (100)376 (48)408 (52)777 (100.0)81 (10.4)696 (89.6)548 (73.3)200 (26.7)748 (100.0)**Demographics**Age, years, mean (SD)53 (16)52 (16)54 (15)0.10453 (16)59 (15)52 (16)0.00050 (15)51 (15)63 (16)0.000Gender, n (%) Male392 (50)183 (48.7)209 (51.2)0.060392 (50.5)37 (45.7)355 (51.0)0.072285 (52.0)97 (48.5)382 (51.1)0.065Ethnicity, n (%) Black2 (0.3)0 (0.0)2 (0.5)2 (0.3)2 (2.5)0 (0.0)1 (0.2)1 (0.5)2 (0.3)0.663 Caucasian709 (90.4)340 (90.4)369 (90.4)704 (90.6)71 (87.7)633 (90.9)493 (90.0)183 (91.5)676 (90.4) Asian4 (0.5)1 (0.3)3 (0.7)4 (0.5)1 (1.2)3 (0.4)4 (0.7)0 (0.0)4 (0.5) Other33 (4.2)13 (3.5)20 (4.9)33 (4.2)2 (2.5)31 (4.5)26 (4.7)6 (3.0)32 (4.3)**Anthropometry**Height, cm, mean (SD)170 (10)170 (10)170 (9)0.416170 (10)169 (10)170 (10)0.421170 (10)169 (10)170 (10)0.243Weight, kg, mean (SD)79 (17)80 (18)78 (16)0.30979 (17)80 (18)79 (17)0.59779 (17)79 (17)79 (17)0.677BMI, kg/m^2^, mean (SD)27.3 (5.8)27.7 (6.6)27.0 (4.9)0.14827.3 (5.8)28.3 (6.5)27.2 (5.7)0.14127.3 (6.0)27.4 (5.0)27.3 (5.8)0.874*Co-morbidities*, n (%) Co-morbidities161 (20.5)84 (22.3)77 (18.9)0.230160 (20.6)30 (37.0)130 (18.7)0.00098 (17.9)59 (29.5)157 (21.0)0.001 COPD47 (6.0)21 (5.6)26 (6.4)0.64347 (6.0)8 (9.9)39 (5.6)0.12732 (5.8)15 (7.5)47 (6.3)0.407 Respiratory19 (2.4)8 (2.1)11 (2.7)0.60519 (2.4)5 (6.2)14 (2.0)0.02212 (2.2)7 (3.5)19 (2.5)0.313 Liver cirrhosis4 (0.5)2 (0.5)2 (0.5)0.9354 (0.5)0 (0.0)4 (0.6)0.4943 (0.5)1 (0.5)4 (0.5)0.937 Chronic kidney failure16 (2.0)4 (1.1)12 (2.9)0.06316 (2.1)4 (4.9)12 (1.7)0.0546 (1.1)9 (4.5)15 (2.0)0.003 Heart failure45 (5.7)27 (7.2)18 (4.4)0.09645 (5.8)10 (12.3)35 (5.0)0.00829 (5.3)14 (7.0)43 (5.7)0.374 Neuro disease12 (1.5)8 (2.1)4 (1.0)0.19112 (1.5)2 (2.5)10 (1.4)0.47611 (2.0)1 (0.5)12 (1.6)0.146**Pre-operative medical history**ASA physical status, n (%)214 (27.4)96 (25.5)118 (29.1)0.007208 (26.8)14 (17.5)194 (27.9)0.000165 (30.1)29 (14.6)194 (26.0)0.000 ASA I395 (50.5)178 (47.3)217 (53.4)395 (51.0)33 (41.3)362 (52.1)292 (53.3)90 (45.2)382 (51.1) ASA II395 (50.5)178 (47.3)217 (53.4)153 (19.7)28 (35.0)125 (18.0)85 (15.5)68 (34.2)153 (20.5) ASA III154 (19.7)87 (23.1)67 (16.5)18 (2.3)5 (6.3)13 (1.9)6 (1.1)11 (5.5)17 (2.3) ASA IV18 (2.3)14 (3.7)4 (1.0)1 (0.1)0 (0.0)1 (0.1)0 (0.0)1 (0.5)1 (0.1) ASA V1 (0.1)1 (0.3)0 (0.0)208 (26.8)14 (17.5)194 (27.9)165 (30.1)29 (14.6)194 (26.0)Functional status, n (%)0.0040.0000.006 Independent708 (90.3)327 (87.0)381 (93.4)702 (90.3)67 (82.7)635 (91.2)506 (92.3)168 (84.0)674 (90.1) Partially dependent62 (7.9)38 (10.1)24 (5.9)62 (8.0)12 (14.8)50 (7.2)33 (6.0)27 (13.5)60 (8.0) Totally dependent13 (1.7)11 (2.9)2 (0.5)12 (1.5)2 (2.5)10 (1.4)8 (1.5)5 (2.5)13 (1.7)ARISCAT score, median (IQR)215 (27.4)102 (27.1)113 (27.7)0.00016 (3; 26)23 (11; 32)16 (3; 24)0.0028 (3; 18)31 (26; 37)16 (3; 26)0.000Smoking, n (%)40 (5.1)23 (6.1)17 (4.2)0.859214 (27.5)22 (27.2)192 (27.6)0.442165 (30.1)44 (22.0)209 (27.9)0.029Transfusion (\< 24 h), n (%)5 (0.6)3 (0.8)2 (0.5)0.21539 (5.0)6 (7.4)33 (4.7)0.00016 (2.9)22 (11.0)38 (5.1)0.000 RBC transfusion (\< 24 h)28 (3.6)16 (4.3)12 (2.9)0.5895 (0.6)1 (1.2)4 (0.6)0.7221 (0.2)4 (2.0)5 (0.7)0.007Respiratory infection (\<30d), n (%)1 (0.1)0 (0.0)1 (0.2)0.32228 (3.6)3 (3.7)25 (3.6)0.0027 (1.3)19 (9.5)26 (3.5)0.000**Laboratory tests and vital signs**Pre-operative values SpO~2~, %, median (IQR)97 (96; 99)97 (96; 98)97 (96; 99)0.23097 (96; 99)97 (95; 98)98 (96; 99)0.00298 (96; 99)96 (94; 98)97 (96; 99)0.000 Hb, (g/dL), mean (SD)13.8 (1.8)13.8 (1.8)13.9 (1.8)0.54013.8 (1.8)13.7 (2.0)13.8 (1.8)0.44214.0 (1.6)13.3 (2.1)13.8 (1.8)0.000 WBC, (cell/mm^3^), mean (SD)7879 (3497)8199 (3097)7568 (3825)0.0197891 (3503)9261 (6168)7721 (2978)0.0007696 (3362)8438 (3845)7905 (3518)0.015 Creatinine, (mg/dL), mean (SD)0.89 (0.69)0.90 (0.86)0.88 (0.49)0.7580.89 (0.69)0.87 (0.28)0.90 (0.73)0.7220.87 (0.59)0.95 (0.91)0.89 (0.70)0.192**Surgical characteristics**Condition, n (%)0.3180.1400.000 Elective717 (91.5)338 (89.9)379 (92.9)712 (91.6)73 (90.1)639 (91.8)513 (93.6)172 (86.0)685 (91.6) Urgency50 (6.4)28 (7.4)22 (5.4)49 (6.3)4 (4.9)45 (6.5)31 (5.7)16 (8.0)47 (6.3) Emergency17 (2.2)10 (2.7)7 (1.7)16 (2.1)4 (4.9)12 (1.7)4 (0.7)12 (6.0)16 (2.1)Planned duration, hours, n (%)0.0000.0000.000 01 (0.1)1 (0.3)0 (0.0)1 (0.1)0 (0.0)1 (0.1) ≤ 2432 (55.1)186 (49.5)246 (60.3)426 (54.8)36 (44.4)390 (56.0)378 (69.0)25 (12.5)403 (53.9) 2--3201 (25.6)90 (23.9)111 (27.2)201 (25.9)15 (18.5)186 (26.7)124 (22.6)73 (36.5)197 (26.3) \> 3150 (19.1)99 (26.3)51 (12.5)149 (19.2)30 (37.0)119 (17.1)46 (8.4)102 (51.0)148 (19.8)Antibiotic prophylaxis, n (%)711 (90.9)338 (90.1)373 (91.6)0.462705 (91.0)74 (91.4)631 (90.9)0.897500 (91.4)184 (92.0)684 (91.6)0.796*P* value refers to the between-groups with Fisher-Freeman-Halton Exact test, Mann Whitney u-test, or Kruskal Wallis test, as appropriate. *N* Number, *IQR* Interquartile range, *SD* Standard deviation, *h* Hours, *d* Days, *PPC* Postoperative pulmonary complications, *COPD* Chronic obstructive pulmonary disease, *ASA* American society of anesthesiologists, *RBC* Blood red cells, *SpO*~*2*~ Blood oxygen saturation, *Hb* Hemoglobin, *WBC* White blood cells

Ventilation variables and intraoperative characteristics {#Sec8}
--------------------------------------------------------

Most of the patients underwent elective surgical procedure (72%), with a median surgical duration of 95 min (1st-3rd interquartile range IQR = 60--160) and median anaesthetic time of 126 min (IQR = 90--192.8 min). The most common ventilation mode was volume-controlled ventilation (VCV) (Table [2](#Tab2){ref-type="table"}). VCV was more commonly used in patients undergoing brain surgery. Median V~T~ was 510 ml (Interquartile range, IQR 475--575), thus resulting in 8 ml/kg predicted body weight (IQR = 7.3--9). Median PEEP level was 5 cmH~2~O (IQR 3--5), Ppeak was 18 cmH~2~O (IQR = 15--21) and driving pressure was 12 (IQR = 11--15) cmH~2~O (Table [2](#Tab2){ref-type="table"}). Table 2Intra-Operative Characteristics of the Patients According to SubgroupsAll PatientsBrainSpine***p*** valueAll patientsPPCNo PPC***p*** valueAll patientsARISCAT\
\< 26ARISCAT\
≥ 26***p*** value***n (%)***784 (100.0)376 (48.0)408 (52.0)777 (100.0)81 (10.4)696 (89.6)748 (100.0)548 (73.3)200 (26.7)**Ventilation and vital signs**Ventilatory mode, n (%)0.0000.3760.452 Volume controlled494 (63.8)259 (70.2)235 (58.0)488 (63.5)50 (64.1)438 (63.5)467 (63.2)341 (62.9)126 (64.0) Pressure controlled149 (19.3)42 (11.4)107 (26.4)149 (19.4)20 (25.6)129 (18.7)146 (19.8)112 (20.7)34 (17.3) Pressure support3 (0.4)2 (0.5)1 (0.2)3 (0.4)0 (0.0)3 (0.4)3 (0.4)1 (0.2)2 (1.0) Spontaneous64 (8.3)21 (5.7)43 (10.6)64 (8.3)4 (5.1)60 (8.7)60 (8.1)42 (7.7)18 (9.1) Other64 (8.3)45 (12.2)19 (4.7)64 (8.3)4 (5.1)60 (8.7)63 (8.5)46 (8.5)17 (8.6)V~T~, ml, median (IQR)510 (475; 575)511 (475; 584)506 (471; 562)0.183510 (475; 575)500 (458; 560)513 (475; 575)0.096510 (475; 572)506 (475; 565)525 (480; 590)0.142V~T~, (ml/kg PBW), median (IQR)8.0 (7.3; 9.0)8.2 (7.3; 9.1)8.0 (7.2; 8.9)0.1508.0 (7.3; 9.0)7.7 (7.0; 8.8)8.1 (7.3; 9.0)0.0608.0 (7.3; 9.0)8.0 (7.3; 9.0)8.0 (7.3; 9.1)0.420PPeak, cmH~2~O, median (IQR)18 (15; 21)18 (15; 21)18 (16; 21)0.22518 (15; 21)18 (16; 21)18 (15; 21)0.18318 (15; 21)18 (15; 21)18 (16; 21)0.061PPlateau, cmH~2~O, median (IQR)16 (14; 19)16 (14; 19)16 (14; 18)0.20116 (14; 19)17 (14; 19)16 (14; 19)0.15016 (14; 19)16 (14; 18)17 (15; 19)0.012PEEP, cmH~2~O, median (IQR)5.0 (3.0; 5.0)5.0 (4.0; 5.0)5.0 (3.0; 5.0)0.6695.0 (3.0; 5.0)5.0 (4.0; 5.0)5.0 (3.0; 5.0)0.2255.0 (3.0; 5.0)5.0 (3.0; 5.0)5.0 (3.3; 5.0)0.156DP, cmH~2~O, median (IQR)12 (11; 15)13 (11; 15)12 (10; 16)0.58512 (11; 15)13 (11; 15)12 (11; 15)0.20112 (11; 15)12 (11; 15)14 (11; 17)0.009RR, bpm, mean (SD)12.0 (1.5)12.1 (1.5)12.0 (1.4)0.23712.0 (1.5)12.1 (1.7)12.0 (1.4)0.66912.0 (1.4)12.1 (1.3)11.9 (1.7)0.188FiO~2~, %, median (IQR)50 (43; 65)50 (40; 60)50 (44; 68)0.02150 (43; 64)50 (46; 65)50 (42; 63)0.58550 (43; 65)50 (43; 70)50 (45; 60)0.143SpO~2~, %, median (IQR)99 (98; 100)99 (99; 100)99 (98; 100)0.16999 (98; 100)99 (98; 100)99 (98; 100)0.23799 (98; 100)99 (99; 100)99 (98; 100)0.069ETCO~2~, mmHg, mean (SD)33 (4)32 (4)33 (5)0.00133 (4)33 (4)33 (5)0.55433 (4)33 (4)33 (5)0.549MP, J/min, median (IQR)6.6 (4.9; 9.2)6.9 (5.0; 10.3)6.2 (4.8; 7.8)0.0586.6 (4.9; 9.2)6.1 (4.8; 10.5)6.6 (4.9; 9.1)0.8566.6 (4.9; 9.3)6.6 (4.9; 8.6)6.7 (5.1; 10.8)0.230MAP, mmHg, mean (SD)80 (12)79 (12)80 (13)0.08379 (12)78 (11)80 (13)0.02179 (12)79 (12)80 (13)0.212Heart rate, bpm, mean (SD)71 (12)69 (12)72 (12)0.00471 (12)68 (12)71 (12)0.16970 (12)71 (12)70 (13)0.355RM, n (%)54 (6.9)29 (7.8)25 (6.1)0.36554 (6.9)29 (7.8)25 (6.1)0.36551 (6.8)36 (6.6)15 (7.5)0.664**Anesthesia characteristics**Opioids, n (%) No2 (0.3)0 (0.0)2 (0.5)2 (0.3)0 (0.0)2 (0.5)90 (12.0)65 (11.9)25 (12.5) Yes782 (99.7)376 (100.0)406 (99.5)0.174782 (99.7)376 (100.0)406 (99.5)0.629746 (99.7)546 (99.6)200 (100.0)0.392Opioids type, n (%)0.0000.0550.836 Short acting221 (28.2)137 (36.4)84 (20.6)220 (28.3)20 (24.7)200 (28.7)2 (0.3)2 (0.4)0 (0.0) Long acting466 (59.4)189 (50.3)277 (67.9)460 (59.2)43 (53.1)417 (59.9)212 (28.3)154 (28.1)58 (29.0)Total fluids, ml, median (IQR)1500 (1000; 2000)1500 (1000; 2000)1500 (1000; 2000)0.0221500 (1000; 2000)1800 (1200; 2125)1500 (1000; 2000)0.0011500 (1000; 2000)1300 (1000; 2000)2000 (1100; 3000)0.000 Cristalloids1175 (1000; 2000)1200 (1000; 2000)1000 (1000; 1500)0.0121200 (1000; 2000)1500 (1000; 2050)1000 (1000; 2000)0.0001200 (1000; 2000)1000 (1000; 1500)1725 (1000; 2475)0.000 Colloids0.0 (0.0; 500.0)0.0 (0.0; 500.0)0.0 (0.0; 500.0)0.6490.0 (0.0; 500.0)0.0 (0.0; 500.0)0.0 (0.0; 500.0)0.7190.0 (0.0; 500.0)0.0 (0.0; 125.0)0.0 (0.0; 500.0)0.649*P*-value refers to the between-groups difference with Fisher-Freeman-Halton Exact test, Mann Whitney u-test, or Kruskal Wallis test, as appropriate. *N* Number; *IQR* Interquartile range, *SD* Standard deviation, *PPC* Postoperative pulmonary complications, *PBW* Predicted body weight, *V*~*T*~ Tidal volume, *PPeak* Peak pressure, *PPlateau* Plateau pressure, *PEEP* Positive end-expiratory pressure, *DP* Driving pressure, *RR* Respiratory rate, *FiO*~*2*~ Fraction of inspired oxygen, *SpO*~*2*~ Blood oxygen saturation, *ETCO*~*2*~ End-tidal carbon dioxide, *MP* Mechanical power, *MAP* Mean arterial pressure, *HR* Heart rate, *RM* Recruitment maneuvers

Routine RMs were performed in 54 patients (6.9%). Unplanned RMs occurred in 1.4% of cases. No statistical difference was found between the spine and brain surgery group or regarding the ventilator settings (Table [2](#Tab2){ref-type="table"}, ESM Figure [S1](#MOESM1){ref-type="media"}). EtCO~2~ values were significantly lower in the brain surgery group compared with the spine surgery group (*p* = 0.001). Patients who developed PPCs received a higher amount of fluids compared to those with no PPCs (Table [2](#Tab2){ref-type="table"}), but no differences were found in the ventilator settings between the two groups (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Ventilation parameters in patients who developed and who did not develop PPCs. Cumulative distribution of Tidal Volume (V~T~) (upper left panel); Cumulative distribution of peak pressure (Ppeak) (upper right panel); Cumulative distribution of plateau pressure (Pplat) (lower left panel); Cumulative frequency distribution of positive end expiratory pressure (PEEP) (lower right panel)

Scatter plots showing the combinations of V~T~ with PEEP, driving pressure, Ppeak, and respiratory rate in patients who developed versus patients who did not develop PPCs, between the spine and brain group, and in patients with low risk \[ARISCAT \< 26\] vs. moderate-to-high risk \[ARISCAT ≥26\] are shown in Fig. [2](#Fig2){ref-type="fig"}, ESM Figures [S2](#MOESM1){ref-type="media"}, [S3](#MOESM1){ref-type="media"}. Fig. 2Combinations of ventilator settings in patients who developed or not developed PPCs. Scatterplots showing distribution of tidal volume with positive end expiratory pressure combinations (upper left panel); tidal volume with Peak pressure (upper right panel); tidal volume with Driving pressure (lower left panel); tidal volume and respiratory rate (lower right panel). Scatter and the fitted line for each of the bivariate plots are shown in blue

Occurrence of PPCs, intraoperative complications and outcomes {#Sec9}
-------------------------------------------------------------

Among the 784 patients included in the analysis, 81 (10.4%) developed PPCs (Table [2](#Tab2){ref-type="table"}). PPCs occurred mainly on day 3. No differences between the surgical groups were found as for probability of PPCs occurrence and hospital length of stay (ESM Figure [S4](#MOESM1){ref-type="media"}).

Patients with ARISCAT≥26 showed an increased probability of PPCs occurrence compared to patients at lower risk (HR 2.50; 95% CI 1.61--3.58, *p* \< 0.000), and of longer hospital length of stay (HR 0.81; 95% CI 0.69.0.97, *p* = 0.019) (ESM Figure [S4](#MOESM1){ref-type="media"}).

Intraoperative episodes of hypotension and the need for vasoactive drugs during the procedure were frequent, especially in the spine group compared to the brain group (38.7% vs 31.2% for hypotension; *p* = 0.028 and 34.6% vs 27.7% for vasoactive drugs, *p* = 0.04, respectively) (Table [3](#Tab3){ref-type="table"}). The incidence of desaturation was less frequent than hypotension or need of vasoactive drugs. No differences were found in terms of mortality or hospital length of stay in patients who developed and did not develop PPCs or the type of surgery. Patients with ARISCAT≥26 compared to those with ARISCAT\< 26, had longer LOS and higher hospital mortality (Table [3](#Tab3){ref-type="table"}). Table 3Outcomes According to SubgroupsAll PatientsBrainSpine***p*** valueAll patientsPPCNo PPC***p*** valueAll patientsARISCAT \< 26ARISCAT ≥ 26***p*** value***n (%)***784 (100.0)376 (48.0)408 (52.0)777 (100.0)81 (10.4)696 (89.6)748 (100.0)548 (73.3)200 (26.7)**PPCs, n (%)**PPCs81 (10.4)46 (12.4)35 (8.6)0.085777 (100.0)81 (10.4)696 (89.6)0.00080 (10.8)43 (7.9)37 (18.6)0.000Need of oxygen69 (8.9)38 (10.2)31 (7.6)0.20281 (10.4)81 (100.0)0 (0.0)0.00068 (9.2)39 (7.2)29 (14.6)0.002Respiratory failure14 (1.8)8 (2.2)6 (1.5)0.47869 (8.9)69 (85.2)0 (0.0)0.00014 (1.9)6 (1.1)8 (4.0)0.010NIV9 (1.2)4 (1.2)5 (1.2)0.96314 (1.8)14 (17.3)0 (0.0)0.0009 (1.3)7 (1.3)2 (1.1)0.801ARDS1 (0.1)1 (0.3)0 (0.0)0.2959 (1.2)5 (6.3)4 (0.6)0.0031 (0.1)0 (0.0)1 (0.5)0.098Pneumothorax1 (0.1)1 (0.3)0 (0.0)0.2951 (0.1)1 (1.2)0 (0.0)0.0031 (0.1)0 (0.0)1 (0.5)0.098**Secondary outcomes, n (%)**Severe PPCs19 (2.4)13 (3.5)6 (1.5)0.06819 (2.4)19 (23.5)0 (0.0)0.00019 (2.6)6 (1.1)13 (6.5)0.000Intra-operative complications344 (43.9)154 (41.1)190 (46.6)0.121342 (44.1)46 (56.8)296 (42.6)0.015336 (44.9)237 (43.2)99 (49.5)0.128Desaturation38 (4.9)23 (6.1)15 (3.7)0.11037 (4.8)11 (13.6)26 (3.7)0.00036 (4.8)21 (3.8)15 (7.5)0.038Unplanned RMs25 (3.2)15 (4.0)10 (2.5)0.22024 (3.1)5 (6.2)19 (2.7)0.09122 (2.9)12 (2.2)10 (5.0)0.043Pressure reduction25 (3.2)11 (2.9)14 (3.4)0.69225 (3.2)3 (3.7)22 (3.2)0.79522 (2.9)17 (3.1)5 (2.5)0.666Flow limitation5 (0.6)3 (0.8)2 (0.5)0.5904 (0.5)1 (1.3)3 (0.4)0.3224 (0.5)2 (0.4)2 (1.0)0.289Hypotension275 (35.1)117 (31.2)158 (38.7)0.028274 (35.3)34 (42.0)240 (34.5)0.185270 (36.1)197 (35.9)73 (36.5)0.890Vasopressors245 (31.3)104 (27.7)141 (34.6)0.040244 (31.4)37 (45.7)207 (29.8)0.004242 (32.4)168 (30.7)74 (37.0)0.101New arrhythmias9 (1.1)6 (1.6)3 (0.7)0.2579 (1.2)0 (0.0)9 (1.3)0.3039 (1.2)5 (0.9)4 (2.0)0.227Hospital LOS, days, median (IQR)2 (1; 5)2 (1; 5)2 (1; 5)0.9932 (1; 5)3 (1; 5)2 (1; 5)0.4472 (1; 5)2 (1; 5)3 (1; 5)0.033Hospital mortality5 (0.7)4 (1.2)1 (0.3)0.1455 (0.7)1 (1.3)4 (0.6)0.5005 (0.7)1 (0.2)4 (2.2)0.006*n* Number, *IQR* Interquartile range, *PPCs* Postoperative pulmonary complications, *NIV* Non-invasive ventilation, *ARDS* Acute respiratory distress syndrome, *LOS* Length of hospital stay, *RMs* Recruitment maneuvers, *ARISCAT* Assess respiratory risk in surgical patients in Catalonia

Risk factors for PPCs {#Sec10}
---------------------

Multivariable logistic regression was used to identify the predictors of PPCs. Duration of anaesthesia was independently associated for the development of PPCs. Analysing the predictors for type of neurosurgery, for age we found a significantly effect in the brain group (the omnibus *p*-value for the neurosurgery-age interaction was *p* = 0.031), but not in the spine group. (Table ESM [S7](#MOESM1){ref-type="media"}, ESM Figure [S5](#MOESM1){ref-type="media"}, Fig. [3](#Fig3){ref-type="fig"}). The effect of age on PPC in the brain group was significant at age above 62 (ESM Figure [S5](#MOESM1){ref-type="media"}). Fig. 3Interaction between type of neurosurgery and age continuous on PPC as outcome. Odds ratio (per 1-unit change in age) is depicted along the continuum of age (years) with its median (53 years) as reference point. Analysis adjusted by duration of anaesthesia, desaturation, and ARISCAT risk score. Indeed, the prognostic effect of age on PPC varies according to neurosurgery subpopulations, with no effect on the spine group, and a significant crescendo effect on the brain group as patient aged

Discussion {#Sec11}
==========

Our results show that: 1) Neurosurgical patients are ventilated with low V~T~ and low PEEP levels, while recruitment manoeuvres are seldom applied. No clinically significant differences exist between the intraoperative ventilator settings and the incidence of PPCs between the subgroups analysed, and in patients undergoing brain and spine surgery. ETCO~2~ levels are generally medium-low, especially in the brain surgery group; 2) PPCs are common, with similar incidence in the spine- and the brain surgical groups; 3) Intraoperative complications occur in a large number of patients (44% of the total population); of these, hypotension and the need for vasopressors are common; 4) Increasing age (for the brain group) and long surgical procedures are independently associated with development of PPCs.

To our knowledge, this is the first prospective observational study in neurosurgical patients specifically focusing on the prevalence of PPCs and the effects of intraoperative mechanical ventilation settings on PPCs development. Our study is a sub-analysis of the LAS VEGAS study \[[@CR10]\], a large international observational study describing the ventilator settings and PPCs occurrence in the perioperative period across different countries, and can therefore be considered representative for the current clinical practice in this population.

Ventilator strategies in patients undergoing neurosurgical interventions {#Sec12}
------------------------------------------------------------------------

Currently applied lung-protective ventilation strategies have shown to reduce PPCs \[[@CR13], [@CR14]\]. In patients undergoing spine surgery, the prone position has various effects on pulmonary function, including a decreased dynamic lung compliance and increased peak inspiratory pressure \[[@CR13]\]; however, no large observational studies or randomized controlled trials are available regarding protective ventilator settings and their effect on PPCs in the prone position in non-ARDS patients.

In brain injured patients, lung-protective ventilation could be deleterious \[[@CR7]\]; in particular, possible high intra-thoracic pressures when using high PEEP levels and permissive hypercapnia can have detrimental effects on cerebral perfusion pressure (CPP) and intracranial pressure (ICP). Therefore, brain injury patients are traditionally ventilated with tidal volumes approximating 9 ml/kg of PBW \[[@CR5]\]. However, recent studies suggest that high V~T~ is a risk factor for acute lung injury even in patients with neurological disorders \[[@CR4]\]. Indeed, our results suggest that the use of low V~T~ is increasingly applied also in neurosurgical patients. Similarly, the application of PEEP in brain injured patients has been traditionally considered detrimental for ICP, by reducing venous outflow \[[@CR15]\]. However, recent evidence demonstrates that PEEP application might not compromise ICP, provided that arterial blood pressure is preserved \[[@CR16], [@CR17]\].

In our cohort, neurosurgical patients were ventilated with low PEEP levels and no differences in PEEP levels were detected between the brain and spine groups. No data is available on the effects of RM in neurosurgical patients and their role within the intraoperative protective ventilation bundle remains unclear. In brain injured patients, RMs can have a dangerous effect on ICP by impairment of jugular blood outflow, and increase of intra-thoracic pressure with impediment of cerebral venous return to the right atrium \[[@CR8]\]. Although pressure-control recruitment manoeuvres improve oxygenation without impairing ICP or CPP, there is still concern regarding their application in neurosurgical patients, and therefore are rarely performed \[[@CR8]\]. Indeed, our results show that recruitment manoeuvres are seldom applied in neurosurgical patients.

To date, no clinical studies comparing pressure-controlled ventilation (PCV) and VCV in brain injured patients are published. In obese \[[@CR18]\], ARDS \[[@CR19]\], and thoracic patients \[[@CR20]\], research suggests no difference in outcome between the modes of ventilation (PCV and VCV). In a trial \[[@CR21]\] including patients undergoing spinal surgery, PCV decreased intraoperative surgical bleeding compared with the VCV group (*p* \< 0.001), possibly by lowering peak inspiratory pressures. A recent randomized controlled trial during lumbar spine surgery demonstrated that hemodynamic variables and arterial blood gas results did not differ significantly between the VCV and PCV with volume guaranteed (PCV-VG) mode groups \[[@CR13]\]. Also, a recent large observational study suggested that PCV is associated with increase of PPC compared to VCV \[[@CR22]\]. This association is not confirmed by our results. In our cohort, patients undergoing spinal surgery were more frequently ventilated with VCV than the brain injured group. However, despite the pathophysiological differences of prone vs supine ventilation, we did not find any other differences in the ventilator settings between the two groups.

In our cohort, ETCO~2~ levels were generally medium-low, with significantly lower values in the brain surgery group compared to the spinal surgery group. This result suggests that patients undergoing brain surgery are more likely to be hyperventilated. This is most likely out of concern for potential increased intracranial pressure.

Although the subgroup with ARISCAT ≥26 shows higher values of driving pressure and plateau pressure (plateau pressure (17 vs 16 cmH~2~O, *p* = 0.012), and higher driving pressure (14 vs 12 cmH~2~O; *p* = 0.009), these values still remain within the recommended ranges for protective ventilation \[[@CR22], [@CR23]\]. In general, in the whole population, a low total energy was applied to the respiratory system \[[@CR23]\] (median mechanical power (6.2 J/min)), with values which remain far from the threshold of 12 J/min suggested as increased risk of lung injury \[[@CR23]\].

Post- operative pulmonary complications {#Sec13}
---------------------------------------

Clinical studies suggest that the application of protective ventilation can reduce PPCs \[[@CR24], [@CR25]\], with high V~T~ identified as an independent predictor of PPCs development \[[@CR26], [@CR27]\]. Trials in obese \[[@CR27]\] and non-obese \[[@CR28]\] patients undergoing abdominal surgery demonstrated that the intraoperative application of high level of PEEP and RMs did not reduce PPCs, when compared with lower PEEP level without RMs.

In our neurosurgical population, 10.3% of patients developed PPCs, similar to the results from the whole population of the LAS VEGAS \[[@CR8]\]. No clinically significant differences exist in the incidence of PPCs when comparing the different intraoperative ventilator settings in the subgroups analysed.

Patients who developed PPCs had worse preoperative conditions (age, ARISCAT score, ASA status), longer duration of anaesthesia (thus suggesting a more complicated surgical procedure), intraoperative complications (in particular hypotension) and the administration of higher volumes of fluid. This latter point is of extreme importance as cerebral and spinal perfusion pressures are generally maintained by the administration of vasopressors and a large amount of fluids; however, a positive fluid balance can increase the risk for pulmonary damage and complications \[[@CR28]\]. Finally, increasing age in the brain surgical group was associated with PPCs occurrence, thus making preoperative assessment extremely important in the management of this group of patients in order to optimize hospital resources and empathetically begin discussions with patients and their carers.

Intraoperative complications and outcomes {#Sec14}
-----------------------------------------

In our cohort, intraoperative complications occurred in a large number of patients (44% of our total population). Moreover, we found an increased prevalence of intraoperative hemodynamic deterioration as compared to respiratory impairment in the intraoperative settings. According to our results, patients undergoing spine surgery have commonly episodes of intraoperative hypotension requiring the use of vasoactive drugs, probably related to the effects of prone position on cardiac function, including a decreased cardiac index \[[@CR13]\].

Our results suggest that in neurosurgical patients, the most common intraoperative complications are related to hemodynamic rather than respiratory function. The fact that hypotension and hemodynamic impairment are common might suggest that limited levels of PEEP could be beneficial in this type of patients by having less negative impact on hemodynamic. These results are in accordance with recently published literature \[[@CR24], [@CR29]\], suggesting that the use of high PEEP can negatively impact the hemodynamic system, thus challenging the traditional concept of "open lung approach", and avoiding repeated alveolar collapse and expansion and keeping the lung partially at rest \[[@CR30]\].

Limitations {#Sec15}
-----------

Several limitations need to be mentioned. First, the manuscript derives from a secondary analysis from the LAS VEGAS study. Thus, the results represent an observation of associations and do not allow to draw causality conclusions, considering that there exist unaccounted confounding factors.

Second, this is an unplanned secondary analysis from the main study, and even though we built a meticulous statistical model, there could still be confounding factors affecting our results.

Third, as the design of the original study focused on intraoperative settings and variables in the general population, limited information was available regarding specific perioperative data in neurosurgical patients, in particular on the use neuro-monitoring and type of brain and spine surgery.

Conclusions {#Sec16}
===========

The main findings of this study are that MV settings in neurosurgical patients are characterized by low V~T~ and low PEEP with seldom use of RMs. PPCs are frequent in this population and not associated with intraoperative ventilator setting. Further studies are warranted to assess the effect of ventilation strategies on the outcome of this cohort of patients.
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